South Korea Cancer Biologic Therapy Market

ID: MRFR/Pharma/52691-HCR
200 Pages
Rahul Gotadki
Last Updated: July 15, 2026
South Korea Cancer Biologic Therapy Market Research Report By Type of Therapy (Monoclonal Antibodies, Vaccines, Cytokines, Gene Therapy), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer), By Administration Route (Intravenous, Subcutaneous, Oral, Intramuscular) and By End User (Hospitals, Cancer Research Institutes, Pharmaceutical Companies) - Growth & Industry Forecast 2025 To 2035
South Korea Cancer Biologic Therapy Market
Market Size
Forecast Period2025-2035
CAGR (2025-2035)7.91%
2023 Market Size$ 2.73 Billion
2024 Market Size$ 3.41 Billion
2035 Market Size$ 7.88 Billion
Key Players
JW Pharmaceutical
Celltrion
AhnGook Pharmaceutical
LG Chem
Medipost
Hanmi Pharmaceutical
Trends
  • Government Support Drives Biotechnology Advancement
  • Industry Collaborations and Regulatory Support Expand Innovation
Opportunities
  • Innovation in Immunotherapy and Biopharmaceutical Development
  • Rising Adoption of Precision Oncology and Targeted Biologic Therapies
Summary Table of Contents Segmentation Download PDF
  1. EXECUTIVE SUMMARY
    1. Market Overview
    2. Key Findings
    3. Market Segmentation
    4. Competitive Landscape
    5. Challenges and Opportunities
    6. Future Outlook
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the study
    3. Research Objective
    4. Assumption
    5. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
    5. Primary Interviews and Information Gathering Process
    6. Breakdown of Primary Respondents
    7. Forecasting Model
    8. Market Size Estimation
    9. Bottom-Up Approach
    10. Top-Down Approach
    11. Data Triangulation
    12. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Value chain Analysis
    2. Porter's Five Forces Analysis
    3. Bargaining Power of Suppliers
    4. Bargaining Power of Buyers
    5. Threat of New Entrants
    6. Threat of Substitutes
    7. Intensity of Rivalry
    8. COVID-19 Impact Analysis
    9. Market Impact Analysis
    10. Regional Impact
    11. Opportunity and Threat Analysis
  6. South South Korea Cancer Biologic Therapy Market, BY Type of Therapy (USD Billion)
    1. Monoclonal Antibodies
    2. Vaccines
    3. Cytokines
    4. Gene Therapy
  7. South Korea Cancer South Korea Cancer Biologic Therapy Market, BY Cancer Type (USD Billion)
    1. Breast Cancer
    2. Lung Cancer
    3. Colorectal Cancer
    4. Prostate Cancer
  8. South South Korea Cancer Biologic Therapy Market, BY Administration Route (USD Billion)
    1. Intravenous
    2. Subcutaneous
    3. Oral
    4. Intramuscular
  9. South South Korea Cancer Biologic Therapy Market, BY End User (USD Billion)
    1. Hospitals
    2. Cancer Research Institutes
    3. Pharmaceutical Companies
    4. Competitive Landscape
    5. Overview
    6. Competitive Analysis
    7. Market share Analysis
    8. Major Growth Strategy in the Cancer Biologic Therapy Market
    9. Competitive Benchmarking
    10. Leading Players in Terms of Number of Developments in the Cancer Biologic Therapy Market
    11. Key developments and growth strategies
    12. New Product Launch/Service Deployment
    13. Merger & Acquisitions
    14. Joint Ventures
    15. Major Players Financial Matrix
    16. Sales and Operating Income
    17. Major Players R&D Expenditure. 2023
    18. Company Profiles
    19. JW Pharmaceutical
    20. Financial Overview
    21. Products Offered
    22. Key Developments
    23. SWOT Analysis
    24. Key Strategies
    25. Celltrion
    26. Financial Overview
    27. Products Offered
    28. Key Developments
    29. SWOT Analysis
    30. Key Strategies
    31. AhnGook Pharmaceutical
    32. Financial Overview
    33. Products Offered
    34. Key Developments
    35. SWOT Analysis
    36. Key Strategies
    37. LG Chem
    38. Financial Overview
    39. Products Offered
    40. Key Developments
    41. SWOT Analysis
    42. Key Strategies
    43. Medipost
    44. Financial Overview
    45. Products Offered
    46. Key Developments
    47. SWOT Analysis
    48. Key Strategies
    49. Hanmi Pharmaceutical
    50. Financial Overview
    51. Products Offered
    52. Key Developments
    53. SWOT Analysis
    54. Key Strategies
    55. SK Bioscience
    56. Financial Overview
    57. Products Offered
    58. Key Developments
    59. SWOT Analysis
    60. Key Strategies
    61. SillaJen
    62. Financial Overview
    63. Products Offered
    64. Key Developments
    65. SWOT Analysis
    66. Key Strategies
    67. Daewoong Pharmaceutical
    68. Financial Overview
    69. Products Offered
    70. Key Developments
    71. SWOT Analysis
    72. Key Strategies
    73. Genexine
    74. Financial Overview
    75. Products Offered
    76. Key Developments
    77. SWOT Analysis
    78. Key Strategies
    79. OncoQuest
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. Curegene
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. PharmAbcine
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Samsung Biologics
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Korea Biotech
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Appendix
    110. References
    111. Related Reports
    112. LIST Of tables
  10. LIST OF ASSUMPTIONS
  11. South Korea Cancer Biologic Therapy Market SIZE ESTIMATES & South Korea Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2019-2035 (USD Billions)
  12. South Korea Cancer Biologic Therapy Market SIZE ESTIMATES & South Korea Cancer Biologic Therapy Market, BY CANCER TYPE, 2019-2035 (USD Billions)
  13. South Korea Cancer Biologic Therapy Market SIZE ESTIMATES & South Korea Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)
  14. South Korea Cancer Biologic Therapy Market SIZE ESTIMATES & South Korea Cancer Biologic Therapy Market, BY END USER, 2019-2035 (USD Billions)
    1. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    2. ACQUISITION/PARTNERSHIP
    3. LIST Of figures
  15. MARKET SYNOPSIS
    1. SOUTH KOREA CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY TYPE OF THERAPY
    2. SOUTH KOREA CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY CANCER TYPE
    3. SOUTH KOREA CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY ADMINISTRATION ROUTE
    4. SOUTH KOREA CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY END USER
  16. KEY BUYING CRITERIA OF CANCER BIOLOGIC THERAPY MARKET
    1. RESEARCH PROCESS OF MRFR
  17. DRO ANALYSIS OF CANCER BIOLOGIC THERAPY MARKET
    1. DRIVERS IMPACT ANALYSIS: CANCER BIOLOGIC THERAPY MARKET
    2. RESTRAINTS IMPACT ANALYSIS: CANCER BIOLOGIC THERAPY MARKET
    3. SUPPLY / VALUE CHAIN: CANCER BIOLOGIC THERAPY MARKET
  18. South Korea Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2025 (% SHARE)
  19. South Korea Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2019 TO 2035 (USD Billions)
  20. CANCER BIOLOGIC South Korea Cancer Biologic Therapy Market, BY CANCER TYPE, 2025 (% SHARE)
  21. CANCER South Korea Cancer Biologic Therapy Market, BY CANCER TYPE, 2019 TO 2035 (USD Billions)
  22. CANCER South Korea Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2025 (% SHARE)
  23. CANCER South Korea Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)
  24. CANCER South Korea Cancer Biologic Therapy Market, BY END USER, 2025 (% SHARE)
  25. CANCER South Korea Cancer Biologic Therapy Market, BY END USER, 2019 TO 2035 (USD Billions)
    1. BENCHMARKING OF MAJOR COMPETITORS

South Korea Cancer Biologic Therapy Market Segmentation

 

 

 

  • South Korea Cancer Biologic Therapy Market By Type of Therapy (USD Billion, 2019-2035)

    • Monoclonal Antibodies
    • Vaccines
    • Cytokines
    • Gene Therapy

 

  • South Korea Cancer Biologic Therapy Market By Cancer Type (USD Billion, 2019-2035)

    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer

 

  • South Korea Cancer Biologic Therapy Market By Administration Route (USD Billion, 2019-2035)

    • Intravenous
    • Subcutaneous
    • Oral
    • Intramuscular

 

  • South Korea Cancer Biologic Therapy Market By End User (USD Billion, 2019-2035)

    • Hospitals
    • Cancer Research Institutes
    • South Korea Cancer Biologic Therapy Market Companies

 

 

 

 

 

 

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.